G6 Materials Corp. Announces Private Placement of $350,000

NEWS

04/10/2020

TSX-V: GGG, OTCQB: GPHBF

Vancouver, BC – G6 Materials Corp.

(the “Company” or “G6”) is pleased to announce its intention to raise up to C$350,000 by way of a non-brokered private placement. The Company will issue up to 5,000,000 Units for total gross proceeds of up to C$350,000 at a price of $0.07 per unit.

Each unit will consist of one common share and one common share purchase warrant. Each common share purchase warrant is exercisable into one common share for a period of two (2) years from closing at a price of $0.12 per share. If the common shares trade on the TSX Venture Exchange at a volume weighted-average price of $0.16 or more per common share for any period of at least ten consecutive trading days after four months plus one day from the initial closing date, the Company shall be entitled to accelerate the expiry time of the warrants to a date that is at least thirty days from the date that notice of such acceleration is given via news release by the Company, with the new expiry time specified in such news release.

Insiders have indicated that they will be participating for a significant portion of the financing.

The Company intends to use the proceeds of the private placement to fund the design, development and marketing of the new graphene enhanced air filtration system and for general working capital purposes.

“With our knowledge of graphene and its properties we have consistently tried to use it to enhance the properties of existing materials and devices. In the current environment we feel that with a relatively small capital injection we have a real opportunity to develop something that could potentially help in mitigating the spread of airborne pathogens.” said Daniel Stolyarov, CEO of G6 Materials Corp.

The closing of the Private Placement is expected to occur on or about April 17, 2020 and is subject to the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange. All securities issued pursuant to the Private Placement will be subject to a four-month hold period in accordance with applicable Canadian securities laws. There is no material fact or material change regarding G6 that has not been generally disclosed.

About G6 Materials Corp.

G6 Materials Corp. is a technology company and world-leader in creating value through the development of innovative graphene-based solutions. The Company is strategically focused on serving the global air filtration and purification market with new products to meet growing demand. G6 also sells a range of graphene-based products and other materials, including but not limited to 3D printing materials, conductive epoxies, fine chemicals, high performance composites and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities.

G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprised of three granted patents, three provisional patents and five patent applications filed. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Located in Ronkonkoma, New York, its premium research laboratory and scalable production facility is equipped with advanced analytical and material processing equipment.

The Company’s e-commerce websites are listed below:

3D Printing

3D printable filaments can be purchased at www.blackmagic3D.com

Conductive Epoxies

Adhesive materials distributed under the G6-EpoxyTM trade name and can be purchased at www.g6-epoxy.com

Fine Chemicals

ChemApproach is a worldwide supplier of a wide variety of unique chemical building blocks, which can be found at http://www.chemapproach.com

R&D Materials

Graphene Laboratories Inc. currently offers over 100 graphene and related products available at Graphene-Supermarket.com

Forward-Looking Information

This news release may contain forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company’s expected future business and financial performance, and often contain words such as “anticipate,” “believe,” “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the risks associated with outstanding litigation, if any; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; the absence of dividends; competition; dilution; the volatility of our common share price and volume; and tax consequences to U.S. shareholders. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates, and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. Albeit the operation of newly suggested products are based on strong scientific evidence, the Company cannot guarantee the performance parameters of the new products and their efficiency against the specific microbes including all types of viruses and bacteria until testing is completed. Further, the Company can not guarantee any outcomes of such testing.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.